About the Authors

Beenish Ali

Roles Methodology, Writing – original draft

Affiliation Department of Pharmacy, Abasyn University, Peshawar, Pakistan

Amjad Khan

Roles Conceptualization, Methodology, Supervision, Writing – review & editing

dr.amjad@kust.edu.pk

Affiliation Department of Pharmacy, Kohat University of Science and Technology (KUST), Kohat, Pakistan

Hamad S. Alyami

Roles Formal analysis, Funding acquisition

Affiliation Department of Pharmaceutics, Najran University, Najran, Saudi Arabia

Majeed Ullah

Roles Formal analysis, Methodology

Affiliation Department of Pharmacy, Kohat University of Science and Technology (KUST), Kohat, Pakistan

Abdul Wahab

Roles Writing – review & editing

Affiliation Department of Pharmacy, Kohat University of Science and Technology (KUST), Kohat, Pakistan

Munair Badshah

Roles Formal analysis, Writing – review & editing

Affiliation Islam College of Pharmacy, Sialkot, Pakistan

Attiqa Naz

Roles Writing – review & editing

Affiliation Department of Pharmacy, Abasyn University, Peshawar, Pakistan

Competing Interests

The authors of this study have read the journal’s policy, and the authors have the following competing interests to declare: Feorzsons Laboratories Ltd. provided material support in the form of API and facilities. The model drug clopidogrel (Mithri Laboratories Ltd. India; purity 99.81% with reference to USP standard) was obtained from Ferozsons Laboratories Ltd. Nowshera, Pakistan. Excipients used in the study, included tablettose-80 (Molkerei Meggle, Germany), microcrystalline cellulose (F.M.C International, Ireland), primojel {sodium starch glycolate} (F.M.C International, Ire Land), Colloidal silicon dioxide {Aerosil-200} (F.M.C International, Ireland), hydroxylpropyl methylcellulose (Merck KGA, Germany), polyvinyl pyrollidone (I.S.P. Technology, Texas), starch maize (I.C.I, Pakistan) and magnesium stearate (Coin Powder International Company Ltd, Taiwan) were purchased from local market of Peshawar, Pakistan. All the excipients were of pharmaceutical grade and were used as received. This does not affect our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.